Navigation Links
Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on February 14, 2013
Date:2/14/2013

CRANBURY, N.J., Feb. 14, 2013 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced results for its second quarter ended December 31, 2012.  Palatin reported a net loss of $1.7 million, or $(0.02) per basic and diluted share, for the quarter ended December 31, 2012, compared to a net loss of $2.6 million, or $(0.08) per basic and diluted share, for the same period in 2011. 

The decrease in net loss for the quarter ended December 31, 2012, compared to the same period last fiscal year, is primarily attributable to an increase in net proceeds from the sale of New Jersey state net operating loss carryforwards, which resulted in the recognition of $1.8 million and $1.1 million, respectively, in tax benefits for the three months ended December 31, 2012 and 2011, and secondarily to a decrease in operating expenses for the periods presented.

REVENUE
Revenues, which consisted of contract revenue pursuant to the collaboration agreement with AstraZeneca, were $6,555 for the quarter ended December 31, 2012 compared to $11,492 for the quarter ended December 31, 2011.

COSTS AND EXPENSES
Total operating expenses for the quarter ended December 31, 2012 were $3.4 million compared to $3.7 million for the comparable quarter of 2011.  The decrease in operating expenses for the quarter was primarily due to lower costs related to Palatin's Phase 2B clinical trial with bremelanotide for Female Sexual Dysfunction (FSD), which Palatin reported positive top-line results on November 8, 2012.

CASH POSITION
Palatin's cash and cash equivalents were $32.9 million as of December 31, 2012, compared to $3.8 million at June 30, 2012, with current liabilities of $2.0 million as of December 31, 2012 compared to $3.5 million as of June 30, 2012
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
3. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
4. Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
5. Palatin Technologies, Inc. To Report Fiscal Year 2012 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2012
6. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012
7. Palatin Technologies Announces Halting of Phase I Clinical Trial of Obesity Compound in AstraZeneca Research Collaboration
8. Palatin Technologies, Inc. Announces Pricing of $35 Million Private Placement of Common Stock and Warrants
9. Palatin Technologies, Inc. To Report Fiscal Year 2012 Fourth Quarter Results; Teleconference and Webcast to be held on September 11, 2012
10. Palatin Technologies Provides Update Regarding Its Obesity Research/Development Collaboration with AstraZeneca
11. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... Eastern Kentucky University is ranked among ... criminal justice degree programs by Nonprofitcollegesonline.com. , “We ... and high quality educational opportunities,” Editor Liz Robertson ... are confident that students will find both at ... site’s first “Students before Profits” list, and EKU ...
(Date:3/31/2015)... 31, 2015  Bayer HealthCare (Bayer) has expanded ... Institute of Technology (MIT) and Harvard University to ... of this new part of the alliance is ... create new cardiovascular therapies. "We are ... Institute to the area of cardiovascular genomics to ...
(Date:3/31/2015)... PHOENIX , March 31, 2015  University of ... John Rogers will deliver the plenary session address ... 2015 International Microwave Symposium (IMS) , kicking off a ... industry growth at the intersection of RF and microwave ... "Soft Assemblies of Radios, Sensors and Circuits for the ...
(Date:3/31/2015)... March 31, 2015 Lighthouse Information ... with operations in California, Oregon, Washington and clients ... its Merger and Acquisition (M&A) Integration Services offering, ... VP Client Services and M&A Integration Practice Leader ... the vast majority of M&A initiatives fail to ...
Breaking Biology Technology:EKU Ranked in Top 50 Among Online Criminal Justice Degrees 2Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease 2Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease 3Health and Engineering Converge at the 2015 International Microwave Symposium 2Health and Engineering Converge at the 2015 International Microwave Symposium 3Lighthouse Information Systems, Inc., Announces Addition of M&A Integration Services 2
... Innovations Inc.,(TSX: ATB), a recognized leading developer, manufacturer ... the health and,nutrition industries, today announced that its ... present a company overview,at the upcoming 28th Annual ... 2008 at 11 am (eastern time), in the ...
... Investment in CogState Ltd. to Support Partnership, ... global implementation of cognitive testing in clinical ... points:, -- United BioSource Corporation (UBC) and CogState ... of cognitive testing in,clinical trials., -- UBC has ...
... NeurogesX, Inc.,(Nasdaq: NGSX ), a biopharmaceutical company ... announced it will,report results for its second quarter 2008 ... A conference call to review the results will begin ... 2008 and will be hosted by Anthony DiTonno,President and ...
Cached Biology Technology:United BioSource Corporation and CogState Ltd. Form Strategic Partnership to Support Cognitive Assessment in Clinical Research 2United BioSource Corporation and CogState Ltd. Form Strategic Partnership to Support Cognitive Assessment in Clinical Research 3United BioSource Corporation and CogState Ltd. Form Strategic Partnership to Support Cognitive Assessment in Clinical Research 4NeurogesX to Report Second Quarter 2008 Financial Results 2NeurogesX to Report Second Quarter 2008 Financial Results 3
(Date:3/11/2015)... BOSTON , March 11, 2015   ... of its platform to scientifically measure and harness ... characteristics to real-time biometrics and objective measurements of ... of music at scale in large populations. It ... scientists, technologists and clinicians perform rigorous studies and ...
(Date:3/10/2015)... , March 10, 2015   Tute Genomics ... has been selected by next-generation sequencing company PrimBio ... whole exome and targeted gene panel interpretation. ... has adopted the most current technologies to support the ... research. The company offers two types of exome sequencing ...
(Date:3/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/48tj8z/global_biometrics ... "Global Biometrics Market Forecast and Opportunities, 2020" ... for biometric authentication systems is projected to grow ... The driving forces for this highly ... projects and constant development in technology. In 2014, ...
Breaking Biology News(10 mins):Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3
... efficiently after injury. But when they don't, otherwise ... surgery or trauma can be stymied. Furthermore, as ... Duchenne Muscular Dystrophy and other degenerative muscle diseases, ... , Researchers from the University of Illinois-Chicago (UIC) ...
... examining how proteins have evolved, UT Southwestern Medical Center ... nature appears to use to design proteins, rules the ... look and function just like their natural counterparts. , ... of the journal Nature, Dr. Rama Ranganathan, associate professor ...
... Caterpillars are bleeding defensive! Insects are known to ... caterpillars has recently shown that, instead, they produce ... pattern recognition receptors (PRR) and antibacterial effectors produced ... against a repeated challenge. These results raise important ...
Cached Biology News:Muscle repair: Making a good system better, faster; implications for aging, disease 2Muscle repair: Making a good system better, faster; implications for aging, disease 3Muscle repair: Making a good system better, faster; implications for aging, disease 4Researchers create functioning artificial proteins using nature's rules 2Researchers create functioning artificial proteins using nature's rules 3The very defensive caterpillar 2
MHC II (HLA-DP)...
The piston kit includes 2 pistons to service one F10 pump of a BioLogic DuoFlow workstation....
BD Primaria 100 mm Cell Culture Dish, surface-modified polystyrene for enhanced cell culture. (200/ca) Packaging: 20 / sleeve, 200 / case ...
BD BioCoat Gelatin 100 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of gelatin....
Biology Products: